Archives

  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Influenza Hemagglutinin (HA) Peptide: Precision Tag for R...

    2025-12-24

    Influenza Hemagglutinin (HA) Peptide: Precision Tag for Reliable Protein Purification

    Principle and Setup: Harnessing the Power of the HA Tag Peptide

    The Influenza Hemagglutinin (HA) Peptide, a synthetic nine-amino acid epitope (YPYDVPDYA), has become an indispensable molecular biology peptide tag for protein detection and purification. Its unique sequence, derived from the influenza hemagglutinin epitope, enables highly specific interactions with Anti-HA antibodies, making it a premier choice for immunoprecipitation (IP), protein-protein interaction studies, and advanced protein purification workflows. The peptide’s competitive binding to Anti-HA antibody facilitates efficient elution of HA-tagged fusion proteins, streamlining the recovery of target proteins and associated complexes.

    With solubility values of ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water, the HA peptide is exceptionally versatile for a variety of buffer systems. Supplied by APExBIO at >98% purity (as confirmed by HPLC and mass spectrometry), this HA tag ensures maximum reproducibility and minimal background, supporting studies that range from mechanistic cancer research to translational drug discovery.

    Step-by-Step Workflow: Enhancing Immunoprecipitation and Protein Purification

    Integrating the Influenza Hemagglutinin (HA) Peptide into your workflow can dramatically increase efficiency and specificity. Below is a robust protocol optimized for HA-tagged protein elution in immunoprecipitation assays:

    1. Sample Preparation

    • Lyse cells or tissues expressing HA-tagged proteins using a suitable buffer (e.g., RIPA or NP-40-based).
    • Clarify lysates by centrifugation at 12,000 x g for 10 min at 4°C.

    2. Immunoprecipitation with Anti-HA Antibody

    • Add Anti-HA magnetic beads or conventional Anti-HA antibodies pre-coupled to Protein A/G beads to the clarified lysate.
    • Incubate at 4°C with gentle agitation for 1–2 hours to allow binding of HA fusion proteins.

    3. Washing

    • Wash beads 3–5 times with ice-cold wash buffer to remove non-specifically bound proteins.

    4. Elution Using HA Peptide

    • Prepare HA peptide elution buffer (recommended final concentration: 1 mg/mL).
    • Incubate beads with elution buffer at 4°C for 30–60 minutes with gentle rotation. The peptide competitively binds to the Anti-HA antibody, releasing the HA fusion protein.
    • Collect the supernatant containing purified HA-tagged protein for downstream analysis (SDS-PAGE, Western blot, mass spectrometry, etc.).

    5. Storage and Stability Considerations

    • Store lyophilized HA peptide desiccated at -20°C for long-term stability.
    • Prepare fresh peptide solutions before each use; avoid long-term storage of diluted solutions to prevent degradation.

    This workflow ensures high recovery and purity of HA-tagged proteins, essential for applications such as the identification of protein-protein interactions, post-translational modification studies, and functional assays.

    Advanced Applications and Comparative Advantages

    The utility of the HA tag sequence extends beyond basic immunoprecipitation. Its epitope specificity and high affinity for Anti-HA antibodies enable researchers to interrogate complex biological questions with precision:

    • Protein-Protein Interaction Studies: The HA tag enables co-immunoprecipitation (co-IP) to uncover protein interaction networks. For example, in studies of ubiquitination pathways and metastasis inhibition (see Dong et al., 2025), HA-tagged constructs allow precise mapping of E3 ligase–substrate interactions.
    • Ubiquitination and Post-Translational Modification Research: The HA peptide is especially valuable for capturing transiently modified proteins, as highlighted in "Influenza Hemagglutinin (HA) Peptide: Precision Tag for Molecular Ubiquitination Studies". Here, its robust binding properties facilitate reliable detection of ubiquitinated substrates.
    • High-Sensitivity Protein Detection: The HA tag’s small size minimizes steric hindrance, making it suitable for both N- and C-terminal fusions without compromising protein function or localization.

    Comparative analyses, such as those described in "Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Purification and Detection", demonstrate that the HA tag outperforms larger or less soluble tags (e.g., FLAG, Myc) in terms of elution efficiency and background reduction. The high solubility and purity >98% further ensure reproducibility across experimental runs, a critical consideration highlighted in "Influenza Hemagglutinin (HA) Peptide: Precision Epitope Tagging", which details how the HA tag enhances reproducibility and throughput in translational studies.

    Troubleshooting and Optimization Tips

    Despite its robust performance, maximizing the utility of the HA tag peptide requires attention to several experimental details:

    • Peptide Concentration: For efficient HA fusion protein elution, a minimum peptide concentration of 1 mg/mL is recommended. Lower concentrations may result in incomplete elution due to insufficient competitive binding to Anti-HA antibody.
    • Buffer Compatibility: The peptide’s high solubility allows its use in most aqueous and organic buffers. However, avoid high concentrations of strong detergents or denaturants that may disrupt antibody-antigen interactions.
    • Antibody Quality: Use validated, high-affinity Anti-HA antibodies or magnetic beads to ensure specific capture and efficient elution of HA-tagged proteins.
    • Minimizing Background: Include appropriate washing steps and negative controls (e.g., untagged lysates) to reduce non-specific binding.
    • Storage Practices: Always store lyophilized peptide at -20°C, desiccated, and prepare fresh solutions before use. Do not freeze-thaw peptide solutions repeatedly.
    • Validation: Confirm the presence of the HA tag at the protein level by Western blot using Anti-HA antibody prior to large-scale purification.

    For more troubleshooting strategies, the article "Influenza Hemagglutinin (HA) Peptide: Elevating Protein Interaction Studies" provides a comprehensive guide to overcoming common bottlenecks, such as low yield or background artifacts, when working with HA-tagged proteins.

    Data-Driven Insights: Quantitative Performance & Reproducibility

    The performance of the HA tag peptide is supported by both peer-reviewed research and practical benchmarking:

    • Elution efficiency with the HA peptide routinely exceeds 90% for most HA-tagged fusion proteins, as measured by densitometric analysis of SDS-PAGE gels.
    • Specificity is consistently high, with background bands reduced by up to 80% compared to non-tag-based purification strategies.
    • Lot-to-lot consistency is ensured by stringent QC (purity >98% by HPLC/MS), supporting reproducibility in longitudinal studies.

    These performance metrics are particularly crucial for studies like the NEDD4L-PRMT5 interaction analysis, where reproducible, high-purity protein complexes are required for meaningful mechanistic insight.

    Future Outlook: HA Tag Peptide as a Platform for Translational Discovery

    The future of HA tag peptide technology lies in its integration into multi-omic workflows, high-throughput screening platforms, and clinical translational research. As highlighted in the thought-leadership perspective "Redefining Precision in Translational Research", the HA tag is central to next-generation mechanistic studies—enabling researchers to dissect ubiquitin signaling, metastasis inhibition, and protein-protein interaction networks at unprecedented resolution.

    Emerging directions include the use of the HA tag in quantitative proteomics (e.g., SILAC, TMT labeling), exosome profiling, and CRISPR-based functional genomics screens, where precise detection and purification of tagged proteins are paramount. Additionally, ongoing advances in antibody engineering and affinity resin design promise further improvements in sensitivity and throughput for HA tag-based assays.

    Conclusion

    In sum, the Influenza Hemagglutinin (HA) Peptide from APExBIO offers unmatched advantages for protein purification, immunoprecipitation, and molecular interaction studies. Its high solubility, epitope specificity, and competitive binding properties streamline even the most demanding research workflows. By integrating this HA tag peptide into your experimental toolkit, you are equipped to tackle both foundational and translational questions with new levels of precision and reliability.